This clinical trial compares the efficacy of continuous glucose monitoring (CGM) vs traditional blood glucose meter monitoring on glycemic control in adults wit
Written by Jowdy Kane Funeral Home
Joseph Carl Conte Sr., age 76, of Bethel, CT, passed away peacefully on Friday, May 28, 2021 with his loving wife Linda (Knapp) Conte by his side.
Joseph was born in Norwalk, CT on February 24, 1945, the son of the late Carl and Madeline (Schiano) Conte. Joe grew up in South Norwalk surrounded by loving family and friends and enjoyed reminiscing at family reunions, sharing treasured memories about the fun times and mischievous antics he and his cousins enjoyed. Being raised in a traditional Italian neighborhood was a treasured memory for Joe which contributed greatly to the hard-working, ethical man that he was. Joe was enthusiastic about life and put 100 percent into everything he endeavored. He put himself through Central Catholic High School in Norwalk, CT and was captain of the football team. He graduated from Central Catholic High in 1963 and joined the Air Force, serving two tours of duty in the Vietnam War as a flight engineer on C-1
By Bill Hathaway
May 25, 2021
Share this with FacebookShare this with TwitterShare this with LinkedInShare this with EmailPrint this
(Illustration by Michael S. Helfenbein)
The primary function of the lung is to facilitate transfer of oxygen to the blood stream. Crucial to this lifegiving task are endothelial cells, which line blood vessels permeating the lung and through which gas exchange occurs.
Malfunction of these cells is implicated in a range of different diseases, including COPD (chronic obstructive pulmonary disease), pulmonary fibrosis, and pulmonary hypertension. And the COVID-19 pandemic has raised important questions about these cells: Why are some endothelium cells, particularly in the elderly, more susceptible to injury from the disease?
A reference map of endothelial cells in the lungs was created to help researchers identify specific abnormalities that occur in a host of lung diseases
Share this article
Share this article
ROCKVILLE, Md., May 20, 2021 /PRNewswire/ Shuttle Pharmaceuticals Holdings, Inc., (Shuttle Pharma) a clinical stage company developing drugs to improve the treatment of cancer patients undergoing radiation therapy is pleased to announce the addition of Chris Senanayake, PhD as a member of its Board of Directors. Shuttle Pharma believes Dr. Senanayake is uniquely qualified to serve as a board member because of his vast experience and expertise in the pharmaceuticals industries.
Dr. Senanayake has more than 30 years of pharmaceutical industry experience, making him an invaluable asset to Shuttle Pharma s mission as the Company advances its pharmaceutical candidates in clinical trials. He is the Founder and Chief Executive Officer (CEO) of TCG GreenChem Inc. and Chief Scientific Officer of TCG Lifesciences, Pvt. Ltd. He has held positions of Senior Scientist at Dow Chemical, Research Fellow at Merck & Co, Inc. Director and Executive Director o